US9286611077 - VNRX (XASE)
VOLITIONRX LTD Share
0,67 USD
Current Prices from VOLITIONRX LTD
Exchange | Ticker | Currency | Last Trade | Price | Daily Change | Daily Change % |
---|---|---|---|---|---|---|
NYSE |
VNRX
|
USD
|
21.12.2024 01:26
|
0,67 USD
| 0,68 USD | -0,15 % |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,00 % | 20,30 % | -17,09 % | 2,26 % | 3,83 % | -0,01 % | -85,55 % |
Company Profile for VOLITIONRX LTD Share
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
Company Data for VOLITIONRX LTD Share
Name VOLITIONRX LTD
Company VolitionRx Limited
Symbol VNRX
Website https://www.volition.com
Primary Exchange
AMEX
ISIN US9286611077
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Mr. Cameron Reynolds MBA
Market Capitalization 66 Mio
Country United States of America
Currency USD
Employees 0,1 T
Address 13215 Bee Cave Parkway, 78738 Austin
IPO Date 2012-03-02
ID Changes
Date | From | To |
---|---|---|
29.09.2011 | SNDC | VNRX |
Ticker Symbols
Name | Symbol |
---|---|
NYSE | VNRX |
More Shares
Investors who VOLITIONRX LTD hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.